Trulance is a once-daily treatment that works locally in the upper gastrointestinal tract to stimulate secretion of intestinal fluid and support regular bowel function, according to a release from the FDA. The drug is not intended for anyone under the age of 18.
“No one medication works for all patients suffering from chronic gastrointestinal disorders,” said Julie Beitz, MD, director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research. “With the availability of new therapies, patients and their doctors can select the most appropriate treatment for their condition.”
More articles on supply chain:
Poor countries permitted to import cheaper generics through new WTO amendment
Bristol-Myers Squibb reaches $625M settlement with Merck in Keytruda-Opdivo patent dispute
Trump initiates meeting with Rep. Elijah Cummings on high drug costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
